PrognomiQ
Philip Ma is Chief Executive Officer, Founder, and Board member for PrognomiQ. Previously, he was Chief Business Officer, President, and Founder of Seer. Prior to this, he was Vice-President for Digital Health Technologies and Data Sciences at Biogen, a group that he established to discover insights and create value for Biogen and its patients. Before joining Biogen, Philip was Senior Partner at McKinsey & Company, where he served global leaders in the pharmaceutical and biotech sectors, leading the West Coast Healthcare Practice and global Personalized Medicine practice for the Firm. Philip was a macromolecular crystallographer in the lab of Dr. Carl O. Pabo at the Massachusetts Institute of Technology, where he received his Ph.D. in Biology. Philip also has degrees in Biochemistry (A.B. from Harvard College) and in Economics (MPhil from Oxford University, where he was a Rhodes Scholar).